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INTRODUCTION
Women, as compared to men, are twice as likely to 
experience depression, and their depressive episodes 
last longer and recur more often (Earls, 1987; Nolen-
Hoeksema, 1987). From the perspective of clinical 
studies, the vulnerability of women to depression is 
associated with hormonal fluctuations during their 
life, particularly to gonadal steroids (Sazdanovic et al., 
2013), in which estrogens have a significant role (Hal-
breich et al., 1986; Hamilton et al., 1988; Pavlovic et 
al., 2013). Indeed, the negative symptomatology asso-
ciated with depression is greater in premenstrual and 
postpartum periods, as well as after menopause or oo-
phorectomy, when women’s 17b-estradiol (E2) levels 
are decreased (Torizuka et al., 2000). Moreover, the 
depressive symptoms of these women are ameliorated 
by chronic treatment with E2 (Ahonkas et al., 1999; 
Osterlund and Hurd, 2001). Preclinical results from 
animal models also suggest that E2 effects depressive-
like behavior. Reduced depressive-like behavior has 
been found in female rats during proestrous, when E2 
levels are high, compared to diestrous, when E2 levels 
are low (Marcondes et al., 2001; Mora et al., 1996). 
In addition, it has been shown that in rodents ovariec-
tomy increases depressive-like behavior, while acute, 
subchronic or chronic physiological E2-replacement 
alleviates these symptoms (Estrada-Camarena et al., 
2003). All these data suggest that alterations in E2 
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levels may be involved in the development of depres-
sion, even though the role of gonadal hormones is not 
completely understood.
Within the multifactorial origins of depression 
(Millan, 2009), chronic inflammation has received in-
creasing attention as a potential contributor in the de-
velopment of the disease (Dantzer et al., 2008; Heyley 
et al., 2005; Lackovic et al., 2013, Messay et al., 2012). 
Indeed, elevated biomarkers of inflammation, including 
inflammatory cytokines and acute-phase proteins, have 
been found in depressed patients (Haroon et al., 2012). 
It has also been shown that gender is a risk factor for 
depression upon the administration of some inflam-
matory stimuli (Pavlovic et al., 2011). Thus, in order 
to explore the effects of female gonadal hormones and 
inflammation in the etiology of depression, we utilized 
a neuroinflammatory model of depression elicited by 
lipopolysaccharide (LPS) administration to naive and 
ovariectomized (OVX) female rats. We also examined 
the effects of E2 and/or progesterone (P4) supplementa-
tion on depressive-like behavior in OVX rats.
MATERIALS AND METHODS 
Animals and treatment
The experiments were performed on adult 3-month-
old female Wistar rats (body mass 250-350 g). All ani-
mals were housed at 20±2°C, with a 12h light/dark 
cycle (lights on at 07:00 h), with food (commercial rat 
pellets) and drinking water available ad libitum. The 
experimental methods were approved by the Ethical 
Committee for the Use of Laboratory Animals of the 
VINCA Institute of Nuclear Sciences, according to 
the guidelines of the EU-registered Serbian Labora-
tory Animal Science Association (SLASA).
Estrous cycle of naive animals
Vaginal smears were collected daily and microscopi-
cally analyzed for determination of the estrous cycle 
stage one week before the start of the experiment. 
Only female rats with normal 4-5 days of estrous 
cycle were included in the study. The vaginal smears 
were examined 24 and 48 h after the last LPS injec-
tion (before the forced swimming pretest and forced 
swimming test) and it was shown that LPS did not 
alter the estrous cycle phase distribution.
Surgical procedure
Ovariectomy was performed under 5% chloral hy-
drate (400 mg/kg) anesthesia. Briefly, a single midline 
incision was made in the ventral area, the oviducts 
were exposed and the ovaries removed (Filova et al., 
2013). The complete extraction of the ovaries was 
corroborated by visual inspection. OVX rats were 
used 2-3 weeks after surgery.
Table 1. Body mass (grams) in naive and OVX rats measured before and after 7-day treatment with saline (SAL), lipopolysaccharide 
(LPS), and hormones (E2 – 17 β – estradiol and P4 – progesterone). Data and presented as mean ± SD p<0.05 (* before and after treat-
ment, # vs Ctrl-SAL).
    day            Ctrl-SAL LPS OVX
Before treatment 265.9±33.9 263.5±25.9 347.5±28.8#
After treatment 275.3±36.1 244.1±20.7* 335.0±25.2
    day            OVX OVX+E2 OVX+P4 OVX+E2P4
Before treatment 315.2±22.7 327.3±38.5 305.0±18.1 335.8±20.0
After treatment 337.1±32.8 335.7±44.7 330.9±18.5* 330.3±25.6
  OVX+LPS OVX+LPS+E2 OVX+LPS+P4 OVX+LPS+E2P4
Before treatment 317.5±24.4 273.8±37.7 286.2±23.3 305.4±24.6
After treatment 307.7±24.3 256.3±30.7 276.3±24.5 268.6±18.6*
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Paradigm and treatments
In order to analyze whether LPS effects on female be-
havior could be modified by 17 β-estradiol (E2) and/
or progesterone (P4), two separate experiments were 
performed. In the first experiment, naive and OVX rats 
were treated intraperitoneally (i.p.) with saline solution 
(SAL) and lipopolysaccharide (LPS) and assigned to 
the following groups: control (SAL, n=14), LPS group 
(500 µg/kg, n=14) and OVX group treated with SAL 
(OVX+SAL, n=10). All groups were treated for the next 
7 days. Dose and duration of LPS treatment were de-
termined in our previous experiments. The applied LPS 
(Escherichia coli 055: B5, No. L-2880, Sigma-Aldrich, 
St. Louis, MO, USA) was previously dissolved in sterile, 
pyrogen-free physiological saline and administered at a 
dose of 500 μg/kg of rat body mass. a fresh solution of 
LPS was prepared on the day of the injection.
In the second experiment, we tested the individual 
effects of the hormones, E2 and P4, as well as their 
joint effect (E2P4) in combination with LPS on OVX 
females. OVX rats were divided into 8 experimental 
groups: OVX-control-control group (OVX+SAL+OIL, 
n=8), OVX-control-E2 group (OVX+SAL+E2, n=8), 
OVX-control-P4 group (OVX+SAL+P4, n=8), OVX-
control-E2P4 group (OVX+SAL+E2P4, n=8), OVX-
LPS-control group (OVX+LPS+OIL, n=8), OVX-LPS-
E2 group (OVX+LPS+E2, n=8), OVX-LPS-P4 group 
(OVX+LPS+P4, n=8) and OVX-LPS-E2P4 group 
(OVX+LPS+E2P4, n=8). The hormones E2 and P4 
(both from Sigma Chemical Co., St Louis, MO) were 
dissolved in sesame oil (Milosevic et al., 2012) and ad-
ministered subcutaneously (sc) every day, parallel with 
LPS injection (500 μg/kg, as described in the first ex-
periment). The treatment lasted for 7 days. Dosages of 
E2 (10 µg/kg) and P4 (4 mg/kg) were chosen on the 
basis that they produce moderate physiological plasma 
levels, both for E2 (Walf et al., 2005) and P4 (Lianeza 
et al., 2009). 
Forced swimming test (FST)
To test depressive-like behavior we used the forced 
swimming test (FST) described previously by Porsolt 
et al. (1977). The FST consisted of two sessions, pre-
test and test. Twenty-four h after the last injection the 
rats were subjected to a pre-test and placed individually 
for 15 min in a Plexiglas cylinder (40 cm height, 20 
cm in diameter) filled with water to a depth of 30 cm 
at 24±0.5°C. The water depth was adjusted to a height 
that did not allow the animals to touch the tank bot-
tom with their hind paws or tails and under conditions 
where escape was not possible. After 15 min they were 
dried and placed in their home cage. Twenty-four h 
after their pre-test, the animals were placed for a 5-min 
test session in the swimming apparatus, and each test 
session was recorded using a video camera in a dimly 
illuminated room. A time sampling technique was used 
whereby the predominant behavior in each 5 s period 
of the 300 s test was recorded. The behaviors measured 
were immobility (i.e., floating and only making the 
movements necessary to keep the rat’s head above wa-
ter), swimming (i.e., horizontal movements throughout 
the swim chamber, which also included crossing into 
another quadrant), and climbing (i.e., making intense 
upward-directed movements of the forepaws along the 
side of the cylinder). Uncontrollable reflex movements 
during periods of immobility, such as shivering or wip-
ing of water away from the eyes, were considered as 
floating (Spasojevic et al., 2008).
Statistical analysis
Data are presented as a mean ± SD. In order to establish 
significant differences in body weight at the beginning 
of the experiment and after treatments, data were ana-
lyzed by Student’s (two-tailed) t-test. Two-way analysis 
of variance (ANOVA) was used to assess the effects of 
E2 and/or P4 on behavior in the forced swimming test 
in LPS- and saline-treated animals. Three-way ANOVA 
was used to analyze the effects of LPS, E2 and/or P4 
treatments on behavior. Only when there was a signifi-
cant main effect and/or interaction effect in the ANO-
VA were post-hoc analyses (Tukey’s test) performed. 
The statistical significance was accepted at p<0.05.
RESULTS
The effect of LPS treatment on body mass
The effects of LPS and OVX treatments on body mass 
changes are presented in Table 1. Body mass was signif-
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icantly decreased by LPS and OVX treatment in respect 
to the control group (p<0.05). In the second experi-
ment, the trend of decrease in body mass was detected 
in all LPS-treated OVX groups, with significant change 
only in the LPS+E2P4-treated OVX group (p<0.05).
The effect of LPS treatment on FST behavior  
of naive and OVX rats
In Fig. 1, both LPS and OVX treatments increased 
immobility (LPS F=21.54, OVX F=66.63, p<0.05) 
and decreased swimming behavior compared to the 
naive group treated with saline (LPS F=6.67, OVX 
F=107.46, p<0.05). In addition, the climbing behavior 
was significantly increased in OVX rats compared to 
the saline group (F=67.09, p<0.05).
Fig. 1. Changes in immobility, swimming and climbing (fre-
quency) in the forced swimming test (FST) in naive and ovariec-
tomized (OVX) rats treated for 7 days i.p. with saline (SAL) and 
lipopolysaccharide (LPS). Data and presented as mean ± SD, p < 
0.05 (* vs SAL).
The effects of LPS, E2 and/or P4 treatments  
on FST behavior of OVX rats
In Fig. 2a, two-way ANOVA revealed that P4 sig-
nificantly decreased immobility (F=14.59, p<0.05) 
and increased climbing behavior (F=16.41, p<0.05) 
of OVX rats in comparison to the OVX-SAL group. 
Furthermore, combined treatment of E2P4 signifi-
cantly increased immobility (E2 x P4 interaction, 
F=57.81, p<0.05) while decreasing swimming (E2 x 
P4 interaction, F=48.71, p<0.05) and climbing (E2 
x P4 interaction, F=4.53, p<0.05) in respect to the 
OVX-SAL group. E2P4 combined treatment also 
significantly decreased climbing behavior in respect 
to the other two OVX-SAL groups treated with indi-
vidual hormones, E2 and P4 (p<0.05) (Fig. 2a), while 
decreased swimming compared to the P4-alone treat-
ment (p<0.05). 
As can be seen in Fig. 2b, two-way ANOVA 
showed that only the E2P4 combined treatment sig-
nificantly increased climbing behavior in comparison 
to all the other OVX-LPS groups (E2 x P4 interac-
tion, F=16.36, p<0.05). Three-way ANOVA revealed 
significant changes in behavior between the OVX-
SAL and OVX-LPS groups only with the combined 
E2P4 treatment (Fig. 2a and b). Namely, E2P4 joint 
treatment significantly decreased immobility (LPSx-
E2xP4 interaction, F=40.78, p<0.05) with a concomi-
tant increase in swimming (LPSxE2xP4 interaction, 
F=22.25, p<0.05) and climbing (LPSxE2xP4 inter-
action, F=19.08, p<0.05) in the OVX-LPS group in 
comparison to the OVX-SAL group.
DISCUSSION
Based on the complexity and heterogeneity of depres-
sion, it is likely that several interacting systems un-
derlie its pathogenesis. Clinical studies indicate that 
inflammatory processes, at least in certain clinical 
subpopulations, are associated with depression. It was 
documented that some depressed patients exhibited 
a disturbed peripheral immune system (Dowlati et 
al., 2010; Schiepers et a., 2005), and that depression 
was manifested as a comorbidity in patients suffering 
from conditions characterized by a systemic inflam-
mation (Anderson et al., 2001; Dickens et al., 2002; 
Khawaja et al., 2009;). Moreover, therapeutic stimu-
lation of the immune system leads to depression in 
hepatitis C patients (Bonaccorso et al., 2001), particu-
larly women (Pavlovic et al., 2011).
A well-established animal model to study behavior-
al and physiological responses under activation of the 
immune system is the administration of bacterial LPS. 
However, experiments on the effects of LPS adminis-
tration on female rats are very scarce. To address this 
question and to evaluate the contributions of female go-
nadal hormones and the immune system in the etiology 
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of depression we used an experimental paradigm where 
naive and ovariectomized rats were injected with 500 
µg/kg LPS7 for 7 consecutive days, with or without par-
allel treatment with estradiol and progesterone.
The first finding of this study was that repeated 
LPS injections reduced body mass. This result is in 
agreement with previous reports showing that high 
doses of LPS induced weight loss (Lugarini et al., 
2002; Hrupka et al., 2001; Plata-Salaman et al., 1993). 
Moreover, it is documented that infection and inflam-
mation in animal models significantly decreased food 
intake (McHugh et al., 1993), and that LPS decreased 
body weight gain by inducing anorexia. On the other 
hand, our data from OVX rats support the notion that 
estrogen deficiency leads to body weight gain and ex-
cessive feeding, which increase the risk of metabolic 
syndrome (Albert et al., 1991; Okada et al., 1993). 
The behavioral profile of the LPS-treated female 
rats differed from that found in the controls. Namely, 
LPS treatment increased immobility and decreased 
swimming. The effects of LPS on female behavior are 
in agreement with the observation of male rodents 
indicating an induction of depressive-like behavior 
after i.p. administration of LPS (Dantzer et al., 2008). 
The profile of the LPS-induced behavioral changes in 
the FST is worth noting because antidepressants that 
enforce serotonergic transmission primarily increase 
swimming, while antidepressants that enhance norad-
renergic transmission predominantly increase climb-
ing (Cryan et al., 2005; Detke et al., 1995). Analagou 
to this, we can speculate that the depression-like be-
havior caused by subchronic LPS administration in 
female rats involves impairment of serotonergic but 
not noradrenergic pathways. 
Ovariectomy (OVX) is utilized as a model of exam-
ining the effect of E2 deprivation in animal models of 
anxiety and depression (Frye et al., 2004; galea et al., 
2001). We found that OVX significantly increased im-
mobility and climbing and decreased swimming, which 
confirmed previous findings. The profile of OVX-in-
duced behavioral changes in the FST indicated impair-
ment in both serotonergic and noradrenergic transmis-
 
 
. Fig. 2. Changes in immobility, swimming and climbing (frequency) in the forced swimming test (FST) in ovariectomized (OVX) rats 
treated for 7 days i.p. with saline (SAL), lipopolysaccharide (LPS), and hormones (solely E2 – 17 β – estradiol, solely P4 – progesterone 
or in combination E2P4). Data and presented as mean ± SD, p < 0.05 (* vs. adjacent vehicle group, # E2P4 vs. other groups, & E2P4 vs. 
P4, and % LPS vs. OVX adjacent group).
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sion. This is not surprising, since it has been reported 
that ovarian hormones may interact with specific sero-
tonergic and noradrenergic transmission (Birzniece et 
al., 2002; Mize and Alper, 2000). Mechanisms by which 
estrogen affects the serotonin transmission include the 
degradation of monoamine oxidase, the enzyme that 
catabolizes serotonin (Luin et al., 1975), and alteration 
of intraneuronal serotonin transport (Sherwin, 1997). 
On the other hand, a decrease in estrogen leads to a 
norepinephrine increase (Douma et al., 2005), which 
in our case could be responsible for the enhancement 
in climbing. Overall, our results confirmed that the ab-
sence of ovarian hormones contributes to the behavior-
al profile of OVX rats by modulating both serotonergic 
and noradrenergic transmission. 
To elucidate further the role of ovarian hormones 
and LPS treatment in the etiology of depressive-like 
behavior we applied LPS, E2 and/or P4 in OVX rats.
Our results regarding chronic E2- and P4-re-
placement therapy in OVX rats are unexpected and 
to some extent contradict each other. Namely, we 
found a positive effect of P4 administration on the 
behavioral profile of OVX rats, while at the same 
time the absence of effect after E2 application and 
a negative effect after E2P4 application on depres-
sive symptomatology of OVX rats. To clarify, P4 
application alone significantly reduced immobility 
and increased climbing behavior, thereby alleviating 
depressive-like symptoms in OVX rats. These results 
are in accordance with a number of papers suggest-
ing that the supplementation of ovarian hormones in 
OVX rats relieves depressive-like behavior (Bekku et 
al., 2006; Bernardi et al., 1989; Estrada-Camarena et 
al., 2003; Frye and Walf, 2002; Rachman et al., 1998; 
Stoffel and Craft, 2004). In addition, this opposite ef-
fect of P4 on immobility and climbing may imply a 
compensatory mechanism in the fine-tuning between 
different neurotransmissions, such as serotonergic 
and noradrenergic, which governs the different com-
ponents of behavior, whereby P4 can relieve depres-
sive-like symptomatology. In contrast to P4, rather 
unexpected effects of E2 and the E2P4 combination 
were obtained. E2 alone had no effect on any of the 
behavioral components, while E2P4 increased im-
mobility. The lack of E2 effect could be explained by 
dosage and/or regimen of E2 application. Namely, our 
chronic E2 administration coincides with some stud-
ies reporting that longer a E2-replacement regimen 
and/or higher E2 dosages may not reduce depressive-
like behavior, similar to our case (galea et al., 2002; 
Martinez-Mota et al., 2000, Morgan and Pfaff, 2001, 
2002; Stoffel and Craft, 2003). On the other hand, the 
increased immobility upon joint E2P4 application in 
OVX rats was contrary to expectations and could be 
in part explained through an opposite effect of the 
ovarian hormones used singly or in combination on 
serotonin autoreceptors and postsynaptic receptors in 
the brain (Birzniece et al., 2001). In particular, it was 
documented that ovarian hormones applied alone or 
in combination differentially influence the 5-HT1A 
receptor in the hippocampal subregions and the ra-
phe nuclei. Such different modulations of the 5-HT1A 
receptor may elucidate the behavioral profile of OVX 
rats treated with a combination of ovarian hormones. 
Another unexpected result of our study con-
cerned hormone supplementation with E2 or P4 in 
OVX rats when exposed to immune challenge. When 
LPS-OVX rats were given individual hormones, no 
changes were found in behavior. In addition, when 
the E2P4 combination was applied, no immobility 
changes were found, but rather increased climbing 
behavior. Additionally, E2P4 treatment of OVX-LPS 
rats markedly changed the behavioral profile, de-
creased immobility and increased swimming and 
climbing in comparison to the OVX-E2P4 group. 
Altogether, our study confirmed that both LPS 
and OVX induce depressive-like behavior in female 
rats. Furthermore, our results potentiate P4 supple-
mentation in the relief of depressive-like symptom-
atology in OVX rats through a fine-tuning of different 
neurotransmissions, such as serotonergic and norad-
renergic, that govern various components of behavior. 
Supplementation of rats with either E and/or P did 
not produce beneficial effects on the response to im-
mune challenge with LPS hormone.
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